188 related articles for article (PubMed ID: 38761272)
1. Early detection of pancreatic cancer in the era of precision medicine.
Ahmed TM; Kawamoto S; Lopez-Ramirez F; Yasrab M; Hruban RH; Fishman EK; Chu LC
Abdom Radiol (NY); 2024 May; ():. PubMed ID: 38761272
[TBL] [Abstract][Full Text] [Related]
2. Recent advances in artificial intelligence for pancreatic ductal adenocarcinoma.
Hayashi H; Uemura N; Matsumura K; Zhao L; Sato H; Shiraishi Y; Yamashita YI; Baba H
World J Gastroenterol; 2021 Nov; 27(43):7480-7496. PubMed ID: 34887644
[TBL] [Abstract][Full Text] [Related]
3. Recent Advances and Future Challenges in Pancreatic Cancer Care: Early Detection, Liquid Biopsies, Precision Medicine and Artificial Intelligence.
Daamen LA; Molenaar IQ; Groot VP
J Clin Med; 2023 Dec; 12(23):. PubMed ID: 38068536
[TBL] [Abstract][Full Text] [Related]
4. A review study on early detection of pancreatic ductal adenocarcinoma using artificial intelligence assisted diagnostic methods.
Sijithra PC; Santhi N; Ramasamy N
Eur J Radiol; 2023 Sep; 166():110972. PubMed ID: 37454557
[TBL] [Abstract][Full Text] [Related]
5. White paper on pancreatic ductal adenocarcinoma from society of abdominal radiology's disease-focused panel for pancreatic ductal adenocarcinoma: Part II, update on imaging techniques and screening of pancreatic cancer in high-risk individuals.
Kulkarni NM; Mannelli L; Zins M; Bhosale PR; Arif-Tiwari H; Brook OR; Hecht EM; Kastrinos F; Wang ZJ; Soloff EV; Tolat PP; Sangster G; Fleming J; Tamm EP; Kambadakone AR
Abdom Radiol (NY); 2020 Mar; 45(3):729-742. PubMed ID: 31768594
[TBL] [Abstract][Full Text] [Related]
6. Early diagnosis of pancreatic cancer: What strategies to avoid a foretold catastrophe.
Tonini V; Zanni M
World J Gastroenterol; 2022 Aug; 28(31):4235-4248. PubMed ID: 36159004
[TBL] [Abstract][Full Text] [Related]
7. Circulating Nucleic Acids as Novel Biomarkers for Pancreatic Ductal Adenocarcinoma.
McGowan R; Sally Á; McCabe A; Moran BM; Finn K
Cancers (Basel); 2022 Apr; 14(8):. PubMed ID: 35454933
[TBL] [Abstract][Full Text] [Related]
8. Application of liquid biopsy for surgical management of pancreatic cancer.
Nagai M; Sho M; Akahori T; Nakagawa K; Nakamura K
Ann Gastroenterol Surg; 2020 May; 4(3):216-223. PubMed ID: 32490335
[TBL] [Abstract][Full Text] [Related]
9. Potential of artificial intelligence in the risk stratification for and early detection of pancreatic cancer.
Tovar DR; Rosenthal MH; Maitra A; Koay EJ
Artif Intell Surg; 2023; 3(1):14-26. PubMed ID: 37124705
[TBL] [Abstract][Full Text] [Related]
10. A Circulating Panel of circRNA Biomarkers for the Noninvasive and Early Detection of Pancreatic Ductal Adenocarcinoma.
Xu C; Jun E; Okugawa Y; Toiyama Y; Borazanci E; Bolton J; Taketomi A; Kim SC; Shang D; Von Hoff D; Zhang G; Goel A
Gastroenterology; 2024 Jan; 166(1):178-190.e16. PubMed ID: 37839499
[TBL] [Abstract][Full Text] [Related]
11. The next "sweet" spot for pancreatic ductal adenocarcinoma: Glycoprotein for early detection.
Xu Y; Wang Y; Höti N; Clark DJ; Chen SY; Zhang H
Mass Spectrom Rev; 2023 Mar; 42(2):822-843. PubMed ID: 34766650
[TBL] [Abstract][Full Text] [Related]
12. High prevalence of mutant KRAS in circulating exosome-derived DNA from early-stage pancreatic cancer patients.
Allenson K; Castillo J; San Lucas FA; Scelo G; Kim DU; Bernard V; Davis G; Kumar T; Katz M; Overman MJ; Foretova L; Fabianova E; Holcatova I; Janout V; Meric-Bernstam F; Gascoyne P; Wistuba I; Varadhachary G; Brennan P; Hanash S; Li D; Maitra A; Alvarez H
Ann Oncol; 2017 Apr; 28(4):741-747. PubMed ID: 28104621
[TBL] [Abstract][Full Text] [Related]
13. Hyperpolarized Magnetic Resonance and Artificial Intelligence: Frontiers of Imaging in Pancreatic Cancer.
Enriquez JS; Chu Y; Pudakalakatti S; Hsieh KL; Salmon D; Dutta P; Millward NZ; Lurie E; Millward S; McAllister F; Maitra A; Sen S; Killary A; Zhang J; Jiang X; Bhattacharya PK; Shams S
JMIR Med Inform; 2021 Jun; 9(6):e26601. PubMed ID: 34137725
[TBL] [Abstract][Full Text] [Related]
14. Overview and Future Perspectives on Tumor-Targeted Positron Emission Tomography and Fluorescence Imaging of Pancreatic Cancer in the Era of Neoadjuvant Therapy.
van Dam MA; Vuijk FA; Stibbe JA; Houvast RD; Luelmo SAC; Crobach S; Shahbazi Feshtali S; de Geus-Oei LF; Bonsing BA; Sier CFM; Kuppen PJK; Swijnenburg RJ; Windhorst AD; Burggraaf J; Vahrmeijer AL; Mieog JSD
Cancers (Basel); 2021 Dec; 13(23):. PubMed ID: 34885196
[TBL] [Abstract][Full Text] [Related]
15. Predicting pancreatic ductal adenocarcinoma using artificial intelligence analysis of pre-diagnostic computed tomography images.
Qureshi TA; Gaddam S; Wachsman AM; Wang L; Azab L; Asadpour V; Chen W; Xie Y; Wu B; Pandol SJ; Li D
Cancer Biomark; 2022; 33(2):211-217. PubMed ID: 35213359
[TBL] [Abstract][Full Text] [Related]
16. Role of Endoscopic Ultrasound in Diagnosis of Pancreatic Ductal Adenocarcinoma.
Chatterjee A; Shah J
Diagnostics (Basel); 2023 Dec; 14(1):. PubMed ID: 38201387
[TBL] [Abstract][Full Text] [Related]
17. An Exosome-based Transcriptomic Signature for Noninvasive, Early Detection of Patients With Pancreatic Ductal Adenocarcinoma: A Multicenter Cohort Study.
Nakamura K; Zhu Z; Roy S; Jun E; Han H; Munoz RM; Nishiwada S; Sharma G; Cridebring D; Zenhausern F; Kim S; Roe DJ; Darabi S; Han IW; Evans DB; Yamada S; Demeure MJ; Becerra C; Celinski SA; Borazanci E; Tsai S; Kodera Y; Park JO; Bolton JS; Wang X; Kim SC; Von Hoff D; Goel A
Gastroenterology; 2022 Nov; 163(5):1252-1266.e2. PubMed ID: 35850192
[TBL] [Abstract][Full Text] [Related]
18. miR-18a and miR-106a Signatures in Plasma Small EVs Are Promising Biomarkers for Early Detection of Pancreatic Ductal Adenocarcinoma.
Xu X; Bhandari K; Xu C; Morris K; Ding WQ
Int J Mol Sci; 2023 Apr; 24(8):. PubMed ID: 37108374
[TBL] [Abstract][Full Text] [Related]
19. Plasma biomarkers for prediction of early tumor recurrence after resection of pancreatic ductal adenocarcinoma.
Rittmann MC; Hussung S; Braun LM; Klar RFU; Biesel EA; Fichtner-Feigl S; Fritsch R; Wittel UA; Ruess DA
Sci Rep; 2021 Apr; 11(1):7499. PubMed ID: 33820913
[TBL] [Abstract][Full Text] [Related]
20. Early Detection Initiative: A randomized controlled trial of algorithm-based screening in patients with new onset hyperglycemia and diabetes for early detection of pancreatic ductal adenocarcinoma.
Chari ST; Maitra A; Matrisian LM; Shrader EE; Wu BU; Kambadakone A; Zhao YQ; Kenner B; Rinaudo JAS; Srivastava S; Huang Y; Feng Z;
Contemp Clin Trials; 2022 Feb; 113():106659. PubMed ID: 34954100
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
